Skip to main content
OpenTrials

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

269 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Active, Not Recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

NCT05506943

Conditions
Adenocarcinoma, Ampullary Cancer, Biliary Tract Cancer, +13 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Medicine Cancer Center Palo Alto, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer

NCT04145141

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

NCT06777316

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +15 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

NCT04430738

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
View all 27 locations
View Trial Details

Related conditions